Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer (see image). The prognosis for patients with ccRCC who undergo surgery to remove a tumor is difficult to predict, however, since outcomes vary. The benefit of tyrosine kinase inhibitor (TKI) therapy-the most frequently used medication administered for ccRCC-also varies between patients.

READ FULL ARTICLE Curated publisher From Medical Express